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Abstract 
Objective: We aimed to assess temporal trends in incidence rates of oesophageal cancer in 
Asian countries. 
Materials and Methods: Using data from the Cancer Incidence in Five Continents series, we 
examined the temporal trends in incidence rates of oesophageal cancer by population and 
histological type in seven Asian countries in 1988 to 2007. Age-period-cohort analyses 
estimated the overall annual percentage changes (net drifts) and their 95% confidence 
intervals (CIs) in incidence rates. 
Results: The age-standardised incidence rate of oesophageal cancer declined in most Asian 
populations, but remained relatively unchanged in Japan and Israel. The rate of oesophageal 
squamous cell carcinoma decreased in Hong Kong, Singapore and Israel, but was stable in 
Japan. The net drifts were statistically significant in men in Hong Kong (-3.4%, 95% CI: -
6.1%, -0.7%) and in women in Singapore (-10.1%, 95% CI: -14.4%, -5.5%). The age-
standardised incidence rates of oesophageal adenocarcinoma were below 2 and 0.5 per 100 
000 in men and women, respectively, across all periods in the all registers containing valid 
data on histological type. The age-standardised incidence rate of oesophageal adenocarcinoma 
slightly increased in Japan, Singapore, and Israel, although the net drift was statistically 
significant only in Israeli men (4.9%, 95% CI: 0.8%, 9.1%). 
Conclusion: The overall incidence rates of oesophageal cancer declined in most Asian 
countries, which is due to a decrease in oesophageal squamous cell carcinoma incidence. 
However, attention needs to be paid to a probable beginning of an increasing incidence of 
oesophageal adenocarcinoma in Asia. 
Key words: Oesophageal cancer; Incidence; Epidemiology; Adenocarcinoma; Asia  
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Abbreviations: ASR, age-standardized incidence rates; BMI, body mass index; CI, 
confidence interval; OAC: oesophageal adenocarcinoma; OSCC: oesophageal squamous cell 
carcinoma; H. pylori, Helicobacter pylori. 
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1. Background 
Oesophageal cancer is the eighth most common type of malignancy and the sixth leading 
cause of cancer deaths globally [1, 2]. It was estimated that there were 456 000 new cases of 
oesophageal cancer worldwide in 2012, among which 340 000 (75%) occurred in Asia. Men 
in Eastern Asia have the highest incidence rate of oesophageal cancer globally (17 per 
100 000) [2].  
The risk factors for the two main histological types of oesophageal cancer, squamous cell 
carcinoma and adenocarcinoma, differ greatly. Oesophageal squamous cell carcinoma is 
mainly associated with tobacco smoking, heavy alcohol use, and certain dietary factors, while 
the main risk factors for oesophageal adenocarcinoma include gastro-oesophageal reflux 
disease , obesity, and Helicobacter pylori (H. pylori) infection (inverse association) [3-6]. 
Oesophageal squamous cell carcinoma is the predominant type in Asia, Africa and South 
America, and accounts for approximately 90% of all oesophageal cancer cases worldwide [2, 
3]. In contrast, oesophageal adenocarcinoma has become the predominant type in most North 
American and European countries. The past four decades have witnessed a rapidly increased 
incidence of oesophageal adenocarcinoma in Western populations, particularly in white males 
[3-5]. 
Asian societies have experienced substantial socio-economic development with changes in the 
exposures in relation to cancer risk during the past several decades [7, 8]. A decreasing 
prevalence of tobacco smoking may have, for example, contributed to a declining risk of 
oesophageal squamous cell carcinoma, while an increased prevalence of obesity or reflux may 
have led to a rise in the incidence of oesophageal adenocarcinoma. To provide an update on 
potential differences in incidence of oesophageal cancer between Asian countries and changes 
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in incidence over time, we analysed the incidence of oesophageal cancer in selected Asian 
countries by histological type using data from the Cancer Incidence in Five Continents series.  
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2. Methods 
2.1. Data sources 
We extracted data on the incidence of oesophageal cancer and population sizes from the 
Cancer Incidence in Five Continents (CI5) series volumes VII to X. These are published by 
the International Agency for Research on Cancer (IARC) and contain information on cancer 
incidence worldwide where good quality data are available [9-12]. We followed the 
geographical definition of the United Nations, which was also in line with the practice in CI5 
series [13]. We included registers in seven Asian countries with available data in all four CI5 
volumes during the period 1988-2007: China (Shanghai and Hong Kong), Japan (Miyagi, 
Nagasaki, and Osaka), India (Chennai and Mumbai), Thailand (Chiang Mai), Singapore, 
Philippines (Manila), and Israel. We pooled the numbers of cases and population sizes at risk 
from multiple regional registers within the country for Japan and India. Evaluation of 
incidence by histological type was restricted to registers with a microscopically verified 
percentage of cases of over 80% in each of the four CI5 volumes (Supplementary Figure 1).  
 
2.2. Statistical analyses 
We first calculated the sex-specific crude and age-standardised incidence rates (ASRs) by 
population and histological type for each CI5 volume in five-year calendar periods. The ASRs 
were calculated using the direct method with the World Health Organisation (WHO) World 
Standard Population 2000 as the reference [14]. The 95% confidence intervals (CIs) of crude 
rates were computed under the assumption of Poisson distribution, while CIs for ASRs were 
estimated based on the gamma distribution, as it assumes that the standardised rate is a 
weighted sum of independent Poisson random variables [15, 16]. All these statistical analyses 
were performed using the statistical software SAS version 9.4 (SAS Institute, Cary, NC). 
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We further performed age-period-cohort regressions on the incidence of oesophageal cancer 
by population and histological type for each sex using a web tool, newly developed by the 
National Cancer Institute (NCI), United States [17]. This web tool fits the age-period-cohort 
model which attempts to differentiate the effects of age, calendar period, and birth cohort on 
disease rates, and estimates the overall annual percentage changes (net drifts) in ASRs in 
addition [17, 18]. The central age group, calendar period, and birth cohort were defined as the 
reference in all age-period-cohort analyses.   
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3. Results 
3.1. Oesophageal cancer of all histological types 
In total, 53 206 men and 18 382 women were diagnosed with oesophageal cancer as recorded 
in all included registers during the period 1988-2007. The ASRs in men were generally 
highest in Eastern Asia, followed by India and Singapore, and were relatively low in Thailand, 
Philippines, and Israel (Table 1). The ASRs in women were highest in India, followed by 
China, and were lower (<3 per 100 000 person-years) in the other populations (Table 1). 
The ASRs of oesophageal cancer declined in both sexes in most Asian populations during the 
study period, but remained relatively stable in Japan and Israel (Figures 1). The decreases in 
net drifts were statistically significant in men in Shanghai (-3.4%, 95% CI: -5.3%, -1.4%), 
Hong Kong (-6.2%, 95% CI: -7.8%, -4.6%), and India (-1.9%, 95% CI: -3.7%, -0.1%). The 
net drifts in women showed decreasing incidence rates with statistical significance in all 
populations, except for Japan (2.9%, 95% CI: -1.5%, 7.6%) and Israel (-0.4%, 95% CI: -4.1%, 
3.5%) (Figure 2 and Supplementary Table 1).  
 
3.2. Oesophageal squamous cell carcinoma 
The incidence rates of oesophageal squamous cell carcinoma were the highest in Hong Kong 
and Japan, followed by Singapore, and were the lowest in Israel (Figure 3 and Supplementary 
Table 2).  
The ASRs of oesophageal squamous cell carcinoma declined in Hong Kong, Singapore and 
Israel, but remained stable in Japan in both sexes (Figure 3). The net drifts were statistically 
significant in men in Hong Kong (-3.4%, 95% CI: -6.1%, -0.7%) and in women in Singapore 
(-10.1%, 95% CI: -14.4%, -5.5%) (Figure 3 and Supplementary Table 1).    
9 
 
 
3.3. Oesophageal adenocarcinoma 
No evident difference in the incidence rates of oesophageal adenocarcinoma between the 
studied Asian populations was seen except for relatively higher rates in Israel since 1993. The 
ASRs of oesophageal adenocarcinoma were below 2 and 0.5 per 100 000 in men and women, 
respectively, across calendar periods in all studied Asian populations (Figure 3 and 
Supplementary Table 3).  
The incidence rates increased in Japan, Singapore, and Israel, although only the net drift in 
Israeli men was statistically significant (4.9%, 95% CI: 0.8%, 9.1%). The percentages of 
oesophageal adenocarcinoma in all cases of oesophageal cancer increased from 3.6% to 11.0% 
and from 13.1% to 37.0% in Singapore and Israel, respectively, from the period 1988-1992 to 
the period 2003-2007 (Supplementary Figure 1). On the contrary, the ASRs of oesophageal 
adenocarcinoma significantly declined in both sexes in Hong Kong during the study period 
(net drifts -8.8% and -8.5% in men and in women, respectively). 
 
3.4. Unspecified and other histological types 
The rate of unspecified histology slightly declined with later calendar periods, while the rate 
of other histological types remained stable over time. However, the rate of unspecified 
histology was low and did not substantially influence the findings for squamous cell 
carcinoma or adenocarcinoma (Supplementary Figure 1).
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4. Discussion 
The present study provided an update on the changing incidence of oesophageal cancer over a 
20-year period in Asia, and revealed variations across populations and histological types. The 
incidence of oesophageal cancer declined in most Asian countries included in this analysis, 
but remained stable in Japan and Israel. This decline was predominantly in oesophageal 
squamous cell carcinoma. There was a seeming trend towards a rise in the incidence of 
oesophageal adenocarcinoma in Singapore and Israel. 
The observed decline in the incidence of oesophageal cancer predominantly in oesophageal 
squamous cell carcinoma is likely to be associated with the decreasing prevalence of tobacco 
smoking over the past few decades in these Asian populations [19-21]. However, the stable 
incidence of oesophageal cancer in Japan did not parallel the decreasing prevalence of 
smoking in this population. It is possible that the influence of a decreasing prevalence of 
smoking has been neutralised by the considerable rise in alcohol consumption in the Japanese 
population [21, 22]. The annual alcohol consumption per capita in people aged 15 and above 
in Japan increased from less than 5 litres in the 1960s to 8 litres in 2003-2005 [22]. Moreover, 
consumption of spirits, which is more strongly associated with the risk of oesophageal 
squamous cell carcinoma than other alcoholic beverages, alone accounted for over half of the 
total alcohol consumption in Japan [23]. Therefore, efforts to reduce the alcohol use could 
decrease the burden of oesophageal cancer in the Japanese population.  
The incidence of oesophageal adenocarcinoma has increased rapidly in many Western 
populations, including North America and Europe, during the past four decades [4, 5], 
whereas data from Asian countries are limited. Earlier studies have shown a statistically non-
significant rise in the incidence of oesophageal adenocarcinoma in Singapore [24], declined 
incidence of oesophageal adenocarcinoma and ratio of adenocarcinoma versus squamous cell 
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carcinoma in Hong Kong [25], and a stable incidence in Japan and Taiwan during the past few 
decades [26, 27]. A recent systematic review of Barrett's oesophagus, regarded as a pre-
malignant condition for adenocarcinoma of the oesophagus, suggested an increasing 
prevalence of this condition in Eastern Asian countries between 1991 and 2014 [28]. The 
present study with updated data till the year 2007 indicates a rise in the incidence of 
oesophageal adenocarcinoma and considerably increased ratio of adenocarcinoma versus 
squamous cell carcinoma in Singapore and Israel. This may be explained by the associated 
rise in the prevalence of reflux and obesity, and the decreased prevalence of H. pylori 
infection in these populations [29-32]. On the other hand, the observed increase may, at least 
partially, be explained by the improvements in histological typing and diagnostic procedures 
over time as shown in other populations [5, 33]. Such speculation is also supported by some 
statistically significant period effects in males from age-period-cohort regressions 
(Supplementary Figure 2). However, these statistical findings need to be interpreted with 
caution given the known co-linearity between effects from calendar periods and birth cohorts 
[17, 18].  Possible misclassification between adenocarcinomas of the oesophagus and gastric 
cardia might have affected the reported incidence rates, but does not seem to influence an 
overall interpretation of the time trends for either of these cancer sites [34]. The decreasing 
trend in the incidence of oesophageal adenocarcinoma in Hong Kong differs from 
observations in Western and other Asian populations, and is also unexpected in a population 
with an increasing prevalence of gastro-oesophageal reflux disease and obesity [29, 35], and a 
decreasing prevalence of H. pylori infection [36]. The only most plausible explanation would 
be the decreasing prevalence of tobacco smoking since the 1980s in Hong Kong [20], 
although there is only a moderately strong association between tobacco smoking and the risk 
of oesophageal adenocarcinoma [37]. We were not able to assess the incidence trends of 
oesophageal adenocarcinoma in Shanghai due to lack of complete data on histology. An 
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earlier study from a high-risk region of China has shown virtually no cases of oesophageal 
adenocarcinoma in this area [38]. Previous reports from a high-risk area of Iran also suggested 
that oesophageal adenocarcinoma remained uncommon in this area [39, 40].  Nevertheless, 
considering the fact that the two major risk factors for oesophageal adenocarcinoma, obesity 
and reflux, are becoming more common in Asian populations, together with the lessons from 
Western countries, a rise in the incidence of oesophageal adenocarcinoma is expected in the 
coming decades in Asia. However, the link between the changing prevalence of reflux, 
obesity and H. pylori infection and the increasing incidence of oesophageal adenocarcinoma 
has been mainly generated in Western populations. The aetiology of oesophageal 
adenocarcinoma in Asian countries, which may differ from that in Western societies, remains 
to be better understood in the future.                                                                                                                                       
The present study has some strengths and limitations. The data from the cancer registers used 
were of good quality in terms of completeness of coverage and accuracy, which lend validity 
to the findings. In addition, the time trends in the incidence of oesophageal cancer were 
further assessed by histological type in several populations. We also performed age-period-
cohort analyses to estimate the overall annual percentage changes (net drifts) in ASRs, which 
represent the temporal trend with adjustment for age and non-linear birth cohort effects. 
Therefore, the net drifts may be considered superior to the annual percentage changes in 
cross-sectional ASRs when interpreting the time trends of disease rates, although the net drifts 
are virtually analogous to the latter [17, 18].  A limitation of this study is that the analyses 
were restricted only to selected cancer registers containing data for the 20-year study period. 
Furthermore, we could perform analyses by histological type in only some countries or 
regions (Hong Kong, Japan, Singapore and Israel) due to lack of complete information on 
histological typing elsewhere. Thus, the results may not be representative for all Asian 
countries, or even for all involved countries, e.g. data from Shanghai not representing the 
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whole China. Racial-ethnic disparities, e.g. Jews versus non-Jews in Israel or Chinese versus 
non-Chinese in Singapore, were not within the scope of this study, but need to be addressed in 
future studies. Finally, any trends in women are difficult to interpret given the low incidence 
rates, resulting in limited statistical precision. Possible explanations for a lower risk of 
oesophageal squamous cell carcinoma in women may be lower prevalence of smoker and 
heavy alcohol use in women, while the reasons for a more striking male predominance of 
oesophageal adenocarcinoma remain incompletely understood [4, 41]. 
In conclusion, the incidence of oesophageal cancer has decreased in some, but not all Asian 
populations from 1988 to 2007. The decrease is attributable to a decline in the incidence of 
oesophageal squamous cell carcinoma, which in turn is likely to be due to the decreasing 
prevalence in tobacco smoking. Oesophageal adenocarcinoma remains uncommon in Asian 
countries. However, there appears to be a trend towards a rise in the incidence of oesophageal 
adenocarcinoma in some Asian populations. This increase might be associated with the 
increasing prevalence of reflux and obesity and the decreasing prevalence of H. pylori 
infection, in these populations. More attention needs to be paid to a possible increase in the 
incidence of oesophageal adenocarcinoma in Asia in the future.  
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Table 1 
Crude and age-standardised incidence rates (ASRs) with 95% confidence intervals (CIs) of oesophageal cancer per 100 000 person-years in selected Asian countries and 
calendar periods during 1988-2007 
Calendar periods 
Males  Females 
N Crude rate (95% CI) ASR (95% CI) 
*
  N Crude rate (95% CI) ASR (95% CI) 
*
 
China (Shanghai)  
1988-1992 2855 15.71 (15.14, 16.30) 14.29 (13.75, 14.86)  1338 7.70 (7.29, 8.12) 5.53 (5.23, 5.84) 
1993-1997 2355 14.34 (13.77, 14.94) 11.20 (10.74, 11.68)  1189 7.51 (7.09, 7.95) 4.63 (4.37, 4.91) 
1998-2002 2291 14.40 (13.81, 15.00) 10.96 (10.50, 11.44)  965 6.22 (5.84, 6.63) 3.63 (3.40, 3.88) 
2003-2007 2017 12.96 (12.40, 13.54) 7.79 (7.45, 8.15)  791 5.16 (4.81, 5.53) 2.42 (2.25, 2.60) 
China (Hong Kong SAR)  
1988-1992 2179 14.91 (14.29, 15.55) 15.72 (15.05, 16.42)  565 4.05 (3.72, 4.40) 3.62 (3.33, 3.94) 
1993-1997 2145 13.78 (13.21, 14.38) 13.03 (12.48, 13.60)  553 3.58 (3.29, 3.89) 2.95 (2.71, 3.22) 
1998-2002 2030 12.41 (11.88, 12.97) 10.54 (10.08, 11.01)  455 2.69 (2.45, 2.95) 2.02 (1.83, 2.22) 
2003-2007 1780 10.89 (10.39, 11.41) 7.96 (7.59, 8.34)  493 2.78 (2.54, 3.03) 1.84 (1.67, 2.02) 
Japan (Miyagi, Nagasaki, and Osaka)  
1988-1992 4114 13.46 (13.05, 13.87) 11.34 (11.00, 11.7)  955 3.00 (2.81, 3.19) 1.98 (1.85, 2.11) 
1993-1997 5256 17.07 (16.61, 17.53) 12.26 (11.93, 12.60)  1100 3.41 (3.21, 3.62) 1.95 (1.84, 2.07) 
1998-2002 6530 21.15 (20.64, 21.67) 12.96 (12.65, 13.28)  1273 3.91 (3.70, 4.13) 1.96 (1.85, 2.08) 
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2003-2007 7595 24.45 (23.9, 25.01) 12.93 (12.63, 13.23)  1494 4.51 (4.28, 4.74) 2.08 (1.97, 2.20) 
India (Chennai and Mumbai)  
1988-1992 2053 5.59 (5.35, 5.83) 10.39 (9.91, 10.89)  1389 4.47 (4.24, 4.71) 7.82 (7.40, 8.26) 
1993-1997 2043 5.12 (4.90, 5.35) 9.41 (8.98, 9.86)  1406 4.16 (3.94, 4.38) 7.16 (6.78, 7.56) 
1998-2002 2177 4.98 (4.78, 5.20) 8.18 (7.82, 8.54)  1384 3.74 (3.55, 3.94) 5.36 (5.07, 5.65) 
2003-2007 1999 4.22 (4.03, 4.41) 6.59 (6.30, 6.89)  1272 3.18 (3.01, 3.36) 4.25 (4.02, 4.50) 
Thailand (Chiang Mai)  
1988-1992 68 1.98 (1.54, 2.51) 2.54 (1.96, 3.22)  47 1.41 (1.03, 1.87) 1.74 (1.27, 2.31) 
1993-1997 73 2.05 (1.61, 2.58) 2.36 (1.85, 2.98)  38 1.07 (0.76, 1.47) 1.20 (0.85, 1.65) 
1998-2002 84 2.27 (1.81, 2.81) 2.49 (1.98, 3.09)  31 0.82 (0.56, 1.17) 0.85 (0.58, 1.22) 
2003-2007 64 1.74 (1.34, 2.22) 1.60(1.23, 2.05)  22 0.57 (0.36, 0.87) 0.48 (0.30, 0.74) 
Singapore  
1988-1992 408 5.95 (5.38, 6.55) 8.67 (7.83, 9.56)  149 2.23 (1.89, 2.62) 2.65 (2.24, 3.11) 
1993-1997 389 5.05 (4.56, 5.58) 6.63 (5.98, 7.33)  116 1.54 (1.28, 1.85) 1.66 (1.37, 2.00) 
1998-2002 390 4.84 (4.37, 5.35) 5.79 (5.22, 6.41)  110 1.37 (1.12, 1.65) 1.40 (1.15, 1.68) 
2003-2007 335 3.89 (3.48, 4.33) 4.10 (3.66, 4.57)  83 0.95 (0.76, 1.18) 0.82 (0.65, 1.02) 
Philippines (Manila)  
1988-1992 143 1.34 (1.13, 1.57) 3.49 (2.90, 4.16)  91 0.80 (0.65, 0.98) 1.96 (1.56, 2.42) 
1993-1997 158 1.27 (1.08, 1.49) 3.49 (2.92, 4.12)  85 0.65 (0.52, 0.81) 1.59 (1.26, 1.96) 
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1998-2002 195 1.51 (1.30, 1.73) 3.47 (2.96, 4.03)  61 0.46 (0.35, 0.59) 0.90 (0.68, 1.16) 
2003-2007 193 1.34 (1.16, 1.55) 2.97 (2.52, 3.46)  83 0.56 (0.44, 0.69) 1.05 (0.82, 1.30) 
Israel  
1988-1992 220 1.87 (1.63, 2.13) 1.91 (1.66, 2.18)  161 1.35 (1.15, 1.58) 1.18 (1.00, 1.38) 
1993-1997 352 2.56 (2.30, 2.85) 2.71 (2.43, 3.02)  212 1.51 (1.32, 1.73) 1.23 (1.07, 1.41) 
1998-2002 358 2.36 (2.12, 2.62) 2.38 (2.14, 2.65)  228 1.47 (1.29, 1.68) 1.08 (0.94, 1.24) 
2003-2007 357 2.17 (1.95, 2.41) 2.09 (1.87, 2.32)  243 1.45 (1.27, 1.64) 1.05 (0.92, 1.20) 
* 
Standardised to the World Health Organization (WHO) World Standard Population 2000. 
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Fig. 1. Age-standardised incidence rates of oesophageal cancer by sex in selected Asian populations in 1988-2007 using the WHO World 
Standard Population 2000 as reference.  
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Fig. 2. The overall annual percentage changes (net drifts) and their 95% confidence intervals 
in the incidence of oesophageal cancer by sex and histological type in selected Asian 
populations in 1988-2007. 
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Fig. 3. Age-standardised incidence rates (ASRs) of oesophageal squamous cell carcinoma (OSCC) and adenocarcinoma (OAC) by sex in 
selected Asian populations in 1988-2007 using the WHO World Standard Population 2000 as reference. 
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Supplementary Table 1. Crude and age-standardised incidence rates (ASRs) with 95% confidence intervals (CIs) of oesophageal squamous cell 
carcinoma per 100 000 person-years by country and calendar period in Asia, 1988-2007 
Calendar 
periods 
Males  Females 
N Crude rate (95% CI) ASR (95% CI) 
*
  N Crude rate (95% CI) ASR (95% CI) 
*
 
China (Hong Kong SAR) 
1988-1992 1538 10.47 (9.95, 11.00) 10.9 (10.35, 11.47)  320 2.28 (2.04, 2.55) 2.04 (1.82, 2.29) 
1993-1997 1662 10.63 (10.13, 11.16) 9.97 (9.49, 10.47)  358 2.31 (2.08, 2.56) 1.93 (1.73, 2.14) 
1998-2002 1725 10.55 (10.06, 11.06) 8.94 (8.52, 9.38)  356 2.10 (1.89, 2.33) 1.59 (1.42, 1.77) 
2003-2007 1533 9.38 (8.92, 9.86) 6.86 (6.52, 7.22)  400 2.25 (2.04, 2.48) 1.51 (1.36, 1.68) 
Japan (Miyagi and Nagasaki) 
1988-1992 1382 15.01 (14.23, 15.82) 11.20 (10.62, 11.81)  248 2.52 (2.22, 2.85) 1.47 (1.29, 1.68) 
1993-1997 1616 17.33 (16.49, 18.19) 11.44 (10.89, 12.02)  294 2.94 (2.62, 3.30) 1.58 (1.40, 1.78) 
1998-2002 1991 21.28 (20.36, 22.24) 12.45 (11.90, 13.02)  338 3.36 (3.01, 3.74) 1.63 (1.45, 1.83) 
2003-2007 2223 24.17 (23.18, 25.20) 12.46 (11.94, 13.01)  355 3.56 (3.20, 3.95) 1.63 (1.45, 1.84) 
Singapore 
1988-1992 332 4.84 (4.33, 5.39) 6.95 (6.22, 7.75)  124 1.86 (1.54, 2.21) 2.20 (1.83, 2.63) 
1993-1997 318 4.13 (3.69, 4.61) 5.39 (4.81, 6.02)  88 1.17 (0.94, 1.44) 1.28 (1.03, 1.58) 
1998-2002 300 3.73 (3.32, 4.17) 4.41 (3.92, 4.95)  78 0.97 (0.77, 1.21) 1.00 (0.79, 1.25) 
2003-2007 267 3.10 (2.74, 3.49) 3.22 (2.84, 3.64)  58 0.66 (0.50, 0.86) 0.58 (0.44, 0.75) 
Israel 
1988-1992 118 1.00 (0.83, 1.2) 1.04 (0.86, 1.24)  121 1.02 (0.84, 1.21) 0.90 (0.74, 1.08) 
1993-1997 128 0.93 (0.78, 1.11) 0.99 (0.82, 1.18)  124 0.89 (0.74, 1.06) 0.72 (0.60, 0.87) 
1998-2002 137 0.90 (0.76, 1.07) 0.90 (0.76, 1.07)  132 0.85 (0.71, 1.01) 0.62 (0.52, 0.75) 
2003-2007 134 0.82 (0.68, 0.97) 0.77 (0.65, 0.92)  148 0.88 (0.75, 1.04) 0.66 (0.55, 0.78) 
*
 Standardised to the World Health Organization (WHO) World Standard Population 2000. 
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Supplementary Table 2. Crude and age-standardised incidence rates (ASRs) with 95% confidence intervals (CIs) of oesophageal 
adenocarcinoma per 100 000 person-years by country and calendar period in Asia, 1988-2007 
Calendar 
periods 
Males  Females 
N Crude rate (95% CI) ASR (95% CI) 
*
  N Crude rate (95% CI) ASR (95% CI) 
*
 
China (Hong Kong SAR) 
1988-1992 170 1.16 (0.99, 1.34) 1.27 (1.08, 1.48)  76 0.54 (0.43, 0.68) 0.46 (0.36, 0.58) 
1993-1997 146 0.93 (0.79, 1.10) 0.91 (0.76, 1.07)  55 0.35 (0.27, 0.46) 0.29 (0.22, 0.38) 
1998-2002 97 0.59 (0.48, 0.72) 0.52 (0.42, 0.63)  29 0.17 (0.11, 0.25) 0.12 (0.08, 0.18) 
2003-2007 71 0.43 (0.34, 0.55) 0.31 (0.24, 0.40)  30 0.17 (0.11, 0.24) 0.10 (0.07, 0.15) 
Japan (Miyagi and Nagasaki) 
1988-1992 46 0.50 (0.37, 0.67) 0.38 (0.28, 0.51)  8 0.08 (0.04, 0.16) 0.04 (0.02, 0.10) 
1993-1997 55 0.59 (0.44, 0.77) 0.40 (0.30, 0.52)  7 0.07 (0.03, 0.14) 0.03 (0.01, 0.08) 
1998-2002 75 0.80 (0.63, 1.01) 0.48 (0.37, 0.60)  12 0.12 (0.06, 0.21) 0.06 (0.02, 0.12) 
2003-2007 86 0.94 (0.75, 1.15) 0.49 (0.39, 0.61)  18 0.18 (0.11, 0.28) 0.07 (0.04, 0.12) 
Singapore 
1988-1992 17 0.25 (0.14, 0.40) 0.34 (0.19, 0.53)  3 0.04 (0.01, 0.13) 0.05 (0.01, 0.15) 
1993-1997 25 0.32 (0.21, 0.48) 0.43 (0.28, 0.64)  7 0.09 (0.04, 0.19) 0.10 (0.04, 0.20) 
1998-2002 49 0.61 (0.45, 0.80) 0.73 (0.53, 0.96)  15 0.19 (0.10, 0.31) 0.18 (0.10, 0.30) 
2003-2007 37 0.43 (0.30, 0.59) 0.48 (0.33, 0.66)  9 0.10 (0.05, 0.20) 0.08 (0.04, 0.16) 
Israel 
1988-1992 39 0.33 (0.24, 0.45) 0.35 (0.25, 0.48)  11 0.09 (0.05, 0.17) 0.08 (0.04, 0.14) 
1993-1997 136 0.99 (0.83, 1.17) 1.07 (0.90, 1.27)  37 0.26 (0.19, 0.36) 0.23 (0.16, 0.32) 
1998-2002 156 1.03 (0.87, 1.20) 1.07 (0.90, 1.25)  50 0.32 (0.24, 0.43) 0.24 (0.18, 0.32) 
2003-2007 169 1.03 (0.88, 1.20) 1.00 (0.86, 1.17)  53 0.32 (0.24, 0.41) 0.23 (0.17, 0.30) 
*
 Standardised to the World Health Organization (WHO) World Standard Population 2000. 
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Supplementary Figure 1. Percentages of histological types of oesophageal cancer in selected 
Asian populations by calendar period during 1988-2007. 
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Supplementary Figure 2. Period and cohort effects and their 95% confidence intervals 
obtained from age-period-cohort analyses for the incidence rates of oesophageal 
adenocarcinoma in men in Singapore and Israel. 
